WO2013062332A3 - Composition anti-vieillissement vasculaire comprenant du syringarésinol - Google Patents

Composition anti-vieillissement vasculaire comprenant du syringarésinol Download PDF

Info

Publication number
WO2013062332A3
WO2013062332A3 PCT/KR2012/008815 KR2012008815W WO2013062332A3 WO 2013062332 A3 WO2013062332 A3 WO 2013062332A3 KR 2012008815 W KR2012008815 W KR 2012008815W WO 2013062332 A3 WO2013062332 A3 WO 2013062332A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition including
syringaresinol
aging composition
vascular anti
vascular
Prior art date
Application number
PCT/KR2012/008815
Other languages
English (en)
Korean (ko)
Other versions
WO2013062332A2 (fr
Inventor
조시영
박찬웅
서대방
김완기
이상준
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to JP2014538710A priority Critical patent/JP6184414B2/ja
Priority to CN201280052927.9A priority patent/CN104023716A/zh
Priority to US14/350,668 priority patent/US9192597B2/en
Publication of WO2013062332A2 publication Critical patent/WO2013062332A2/fr
Publication of WO2013062332A3 publication Critical patent/WO2013062332A3/fr
Priority to HK14110430.1A priority patent/HK1197019A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne une composition anti-vieillissement vasculaire comprenant un composé de la formule chimique 1, un dérivé de celui-ci ou un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif.
PCT/KR2012/008815 2011-10-27 2012-10-25 Composition anti-vieillissement vasculaire comprenant du syringarésinol WO2013062332A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2014538710A JP6184414B2 (ja) 2011-10-27 2012-10-25 シリンガレシノールを含む血管老化抑制用組成物
CN201280052927.9A CN104023716A (zh) 2011-10-27 2012-10-25 包括丁香树脂醇的抗血管老化组合物
US14/350,668 US9192597B2 (en) 2011-10-27 2012-10-25 Composition for inhibiting vascular aging comprising syringaresinol
HK14110430.1A HK1197019A1 (en) 2011-10-27 2014-10-20 Vascular anti-aging composition including syringaresinol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0110486 2011-10-27
KR1020110110486A KR20130046115A (ko) 2011-10-27 2011-10-27 시링가레시놀을 포함하는 혈관 노화 억제용 조성물

Publications (2)

Publication Number Publication Date
WO2013062332A2 WO2013062332A2 (fr) 2013-05-02
WO2013062332A3 true WO2013062332A3 (fr) 2013-06-20

Family

ID=48168727

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/008815 WO2013062332A2 (fr) 2011-10-27 2012-10-25 Composition anti-vieillissement vasculaire comprenant du syringarésinol

Country Status (6)

Country Link
US (1) US9192597B2 (fr)
JP (1) JP6184414B2 (fr)
KR (1) KR20130046115A (fr)
CN (1) CN104023716A (fr)
HK (1) HK1197019A1 (fr)
WO (1) WO2013062332A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6126107B2 (ja) * 2011-10-18 2017-05-10 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ シリンガレシノールを含むｓｉｒｔ−１活性化剤
KR20160107488A (ko) 2015-03-04 2016-09-19 (주)아모레퍼시픽 백신효과 증진 또는 개선용 조성물
KR101864121B1 (ko) * 2015-10-08 2018-06-04 충남대학교산학협력단 섬오갈피 추출물을 함유하는 혈관질환의 예방 또는 치료용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519673A1 (fr) * 1991-06-15 1992-12-23 Suntory Limited Composition à base de dérivés de dioxabicyclo[3.3.0]octane
EP0729753A1 (fr) * 1995-02-01 1996-09-04 Suntory Limited Agents pour le traitement et la prévention de l'hypertonie et des symptÔmes et des troubles connexes, leur préparation et utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330416A (ja) * 1986-07-24 1988-02-09 Wakunaga Pharmaceut Co Ltd 脳循環代謝改善剤
KR20040050396A (ko) 2002-12-10 2004-06-16 한국식품개발연구원 천궁을 이용한 일산화질소 생성제 조성물 및 이를 이용한약품 조성물
KR20080104600A (ko) * 2007-05-28 2008-12-03 (주)아모레퍼시픽 인삼 열매 추출물을 함유하는 혈행촉진, 혈관신생촉진, 및허혈성 심질환 치료용 조성물
JP5455413B2 (ja) * 2008-03-31 2014-03-26 株式会社 資生堂 血管の成熟化・正常化・安定化剤
KR101614110B1 (ko) * 2008-11-28 2016-04-21 (주)아모레퍼시픽 동맥경화 예방 또는 치료용 조성물
JP6126107B2 (ja) * 2011-10-18 2017-05-10 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ シリンガレシノールを含むｓｉｒｔ−１活性化剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519673A1 (fr) * 1991-06-15 1992-12-23 Suntory Limited Composition à base de dérivés de dioxabicyclo[3.3.0]octane
EP0729753A1 (fr) * 1995-02-01 1996-09-04 Suntory Limited Agents pour le traitement et la prévention de l'hypertonie et des symptÔmes et des troubles connexes, leur préparation et utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JUNG, H.J. ET AL., PLANTA MEDICA, vol. 69, 2003, pages 610 - 616 *

Also Published As

Publication number Publication date
US9192597B2 (en) 2015-11-24
HK1197019A1 (en) 2015-01-02
CN104023716A (zh) 2014-09-03
WO2013062332A2 (fr) 2013-05-02
US20140248381A1 (en) 2014-09-04
KR20130046115A (ko) 2013-05-07
JP6184414B2 (ja) 2017-08-23
JP2015501318A (ja) 2015-01-15

Similar Documents

Publication Publication Date Title
WO2013091775A3 (fr) Utilisation de dérivés du cyclohéxanol comme principes actifs antimicrobiens
EP4071149A3 (fr) Composés hétérocycliques et leurs utilisations
WO2011012816A3 (fr) Formulation pharmaceutique
MX2014002014A (es) Formulaciones, uso de las mismas como o para producir detergentes para lavado de vajillas y produccion de las mismas.
WO2014144545A3 (fr) Benzoxazoles substitués et leurs procédés d'utilisation
WO2009111653A3 (fr) Agents thérapeutiques antiviraux
WO2014009833A3 (fr) Modulateurs de trajet de complément et leurs utilisations
WO2013009527A3 (fr) Inhibiteurs du facteur ixa
WO2012101011A3 (fr) Nouveaux dérivés d'arylbenzocycloalkylamides
WO2012122011A3 (fr) Amino-quinoléines en tant qu'inhibiteurs de kinase
WO2013100566A8 (fr) Composé de dérivés de carbamate d'alkyle phényle et composition pharmaceutique en contenant
WO2014031872A3 (fr) Inhibiteurs à petites molécules pour le traitement d'infections parasitaires
WO2013055687A3 (fr) R(+)-n-formyl-propargyl-aminoindane
WO2011157722A3 (fr) Composition contenant de l'ivabradine solide
WO2010129918A8 (fr) Promédicaments à base de triptolide
WO2012070062A3 (fr) Nouveau polymorphe de chlorhydrate de nilotinib
WO2012140596A8 (fr) Dérivés de glycoside et leurs utilisations
WO2013109388A8 (fr) Dérivés de 1,5-naphtyridine et inhibiteurs de melk les contenant
WO2012118308A3 (fr) Composition contenant un dérivé de pyrazole destinée à prévenir et à traiter les maladies cardiovasculaires
MX2014001604A (es) Compuestos de antranilamida y sus usos como plaguicidas.
WO2014159794A3 (fr) Modulateurs de récepteurs gpr120 à base d'acide bicyclo [2.2.1]
WO2013169746A3 (fr) N-ethyl-4-hydroxyl-1-méthyl-5-(méthyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-n-phényl-1,2-dihydroquinoléine-3-carboxamide
NZ627473A (en) Aryloxyacetamide compound and pesticide
MX2014001510A (es) Compuestos de antranilamida y sus usos como plaguicidas.
TN2012000105A1 (en) Spirolactam derivatives and uses of same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12843282

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14350668

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2014538710

Country of ref document: JP

Kind code of ref document: A

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22/08/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12843282

Country of ref document: EP

Kind code of ref document: A2